Mercado de Citometria de Fluxo do Médio Oriente e África – Tendências do Setor e Previsão para 2030

Análise e insights do mercado de citometria de fluxo no Médio Oriente e África

O mercado da citometria de fluxo no Médio Oriente e em África é impulsionado por factores como a crescente prevalência de doenças crónicas, a crescente procura de novas tecnologias no mercado da citometria de fluxo, o que aumenta a sua procura, bem como o aumento do investimento em investigação e desenvolvimento, o que leva ao crescimento do mercado. Atualmente, os gastos em saúde têm aumentado nos países desenvolvidos e emergentes, o que deverá criar uma vantagem competitiva para os fabricantes desenvolverem novos e inovadores mercados de citometria de fluxo. No entanto, prevê-se que o elevado custo dos instrumentos de citometria de fluxo restrinja o crescimento do mercado de citometria de fluxo no Médio Oriente e em África.

Espera-se que o mercado de citometria de fluxo no Médio Oriente e em África ganhe crescimento de mercado no período de previsão de 2023 a 2030. A Data Bridge Market Research analisa que o mercado está a crescer com um CAGR de 6,9% no período de previsão de 2023 a 2030 e prevê-se que atinja os 95,86 milhões de dólares até 2030, contra 56,73 milhões de dólares em 2022.

O relatório de mercado de citometria de fluxo do Médio Oriente e África fornece detalhes de quota de mercado, novos desenvolvimentos e análise de pipeline de produtos, o impacto dos participantes do mercado doméstico e localizado, analisa as oportunidades em termos de bolsas de receitas emergentes, mudanças nas regulamentações de mercado, aprovações de produtos, decisões de estratégia, lançamentos de produtos, expansões geográficas e inovações tecnológicas no mercado. Para compreender a análise e o cenário do mercado, contacte-nos para um resumo do analista. A nossa equipa irá ajudá-lo a criar uma solução de impacto na receita para atingir a meta desejada. A escalabilidade e expansão do negócio das unidades de retalho nos países em desenvolvimento de diversas regiões e a parceria com fornecedores para a distribuição segura de máquinas e medicamentos são os principais impulsionadores que impulsionaram a procura do mercado no período de previsão.

Market Definition

Flow cytometry is a key process for screening cells from a heterologous cell mixture used in cell sorting, counting, protein regeneration, and engineering. The analysis of cell surface and intracellular molecule expression, the characterization and definition of various cell types in a heterogeneous cell population, the evaluation of the purity of isolated subpopulations, and the measurement of cell size and volume are all common uses for flow cytometry. It enables the simultaneous examination of multiple parameters for a single cell. A flow cytometer uses lasers to produce light, which is subsequently dispersed by the sample's cells, recorded by detectors, and converted into signals for analysis and measurement.

The increasing innovations and technologies, rising number of players in the market, and novel product launches are also propelling the growth of the Middle East and Africa flows cytometry market.

Middle East and Africa Flow Cytometry Market Dynamics

Drivers

• Rising prevalence of chronic diseases

These increasing prevalence and incidences of chronic diseases are likely to drive market growth by focusing on cytometry devices. The increasing incidences of diseases lead to an increase in the Middle East and Africa market as many companies are investing in research and development. This resulted in the enormous lead in demand for advancements to diagnose the disease through quick and accurate techniques.

For instance,

• In January 2021, according to a World Health Organization report, cancer became the major cause of death in 2020, with 10 million in approximation, where often cases were of breast cancer (2.26 million), lung (2.21 million), colon and rectum (1.93 million); prostate (1.41 million), skin (1.20 million) and stomach (1.09 million)

Therefore, this is raising the demand for the Middle East and Africa flow cytometry market.

• Increasing application of cytometry instruments

Technological developments in cytometry instruments are rising by combining several new techniques to provide high resolution and sensitivity to quantify new entities of cells.

The immunophenotypic analysis is important not only for the initial diagnosis and categorization of acute leukemia, chronic lymphoproliferative disorders, and malignant lymphomas but also for their treatment. Flow cytometry can be used as a sensitive assay to track patients' improvement after chemotherapy or transplantation and detect minimal residual illness (MRD).

For instance,

• In January 2022, Becton, Dickinson and Company, a Middle East and Africa medical technology company, announced that a study conducted in collaboration with the European Molecular Biology Laboratory (EMBL) and published the new BD innovation in flow cytometry that adds fluorescence imaging and image-based deaccessioning to sort individual cells at exceptionally high speed, based on the visual details of each cell rather than the type or quantity of biomarkers present. The novel method has the potential to revolutionize immunology, cell biology, and genomics research, as well as enable the development of new cell-based therapeutics

 Thus, this is expected to act as a driver for the growth of the Middle East and Africa flow cytometry market.

Opportunities

• Strategic initiatives by market players

With the increasing burden of infectious diseases such as COVID-19 and chronic diseases such as cancer, the demand for advanced research in the region is high—the dramatic rise in the quality of research worldwide.

• In August 2021, BD launched its new Benchtop cell analyzer, "BD FACSymphony A1 Cell Analyzer," which brings sophisticated flow cytometry capabilities to laboratories of all sizes. This fluorescence-activated cell sorter (FACS) technology enables good isolation and provides access to various flow cytometry experiments in their laboratories. This improved their revenue over the segment
• In June 2019, Agilent Technologies Inc. acquired ACEA Biosciences and launched their new product, "Agilent NovoCyte Advanteon Flow Cytometer," at the 34th congress of the International Society for Advancement of Cytometry, CYTO 2019 congress. This new product enabled the company to mark its footprint in the flow cytometry market

Also, the strategic initiatives taken by key market players will provide structural integrity and future opportunities for the Middle East and Africa flows cytometry market in the forecast period of 2023-2030.

Restraints/Challenges

• High cost of flow cytometry instruments

Flow cytometers come in a variety of shapes and sizes, although benchtop instruments are the most common. They offer optimal data analysis, the convenience of use, and upgrades and options for various systems, all of which are intended to solve customized separations, cell/particle sorting, exploratory cell analysis, and other issues. All flow cytometers feature three common components – fluids, optics, and electronics/informatics.

Flow cytometers are very expensive especially considering the cost associated with repair and maintenance.

• Lack of skilled professionals

The lack or shortage of skilled expertise would restrain the pace of recovery and growth in one place. Often the people who are unemployed in one place have skills that are in short supply elsewhere. Moreover, rapid technological advancement in this field also leads to a lack of expertise.

Flow cytometry is a sophisticated instrument that can concurrently measure the size and granularity of a single cell as it moves through a measurement device in suspension. Cell sorters and flow cytometry analyzers can be operated by persons who have been educated in safety procedures. Hence, this is expected to impede the market growth.

COVID-19 Impact on the Middle East and Africa Flow Cytometry Market

COVID-19 has positively affected the market due to disease diagnosis and research purposes, which raises the demand for flow cytometry during this period.

Recent Development

• In January 2022, Sony Biotechnology, Inc. presented a novel closed cell isolation system CGX10 for use in GMP-compliant cell sorting applications. With the initiative, new growth opportunities were hoped for the company. Such advances in technology will lead to cost-effectiveness, greater accuracy and portability and are likely to create future growth opportunities.

Middle East and Africa Flow Cytometry Market Scope

Middle East and Africa flow cytometry market is segmented into product, technology, application, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Product

• Reagents and consumables
• Flow cytometry instruments
• Accessories
• Services
• Software

On the basis of product, the Middle East and Africa flow cytometry market is segmented into flow cytometry instruments, reagents and consumables, software, accessories, and services.

Technology

• Cell-based flow cytometry
• Bead-based flow cytometry

On the basis of technology, the Middle East and Africa flow cytometry market is segmented into cell-based flow cytometry and bead-based flow cytometry.

Application

• Research applications
• Clinical applications
• Industrial applications

On the basis of application, the Middle East and Africa flow cytometry market is segmented into research applications, clinical applications, and industrial applications.

End User

• Empresas farmacêuticas e de biotecnologia
• Institutos académicos e de investigação
• Hospitais
• Laboratórios de ensaios clínicos
• Banco de sangue
• Outros

Com base nos utilizadores finais, o mercado de citometria de fluxo do Médio Oriente e de África está segmentado em institutos académicos e de investigação, hospitais, empresas farmacêuticas e de biotecnologia, laboratórios de ensaios clínicos, bancos de sangue, entre outros.

Canal de distribuição

• Vendas no retalho
• Licitações diretas

Com base no canal de distribuição, o mercado de citometria de fluxo do Médio Oriente e África está segmentado em vendas a retalho e propostas diretas.

Análise/perspetivas regionais do mercado de citometria de fluxo no Médio Oriente e África

O mercado de citometria de fluxo do Médio Oriente e África é analisado, e os insights e tendências do tamanho do mercado são fornecidos por país, produto, tecnologia, aplicação, utilizador final e canal de distribuição, como mencionado acima.

A África do Sul é o principal país dominante no mercado devido ao aumento das iniciativas estratégicas dos principais intervenientes no mercado para melhorar os negócios e aumentar a sensibilização entre a população do país. E estão a dominar o mercado da citometria de fluxo em termos de quota de mercado e receitas de mercado e continuarão a florescer durante o período de previsão.

A secção do país do relatório também fornece fatores individuais de impacto no mercado e alterações nas regulamentações do mercado que impactam as tendências atuais e futuras do mercado. Pontos de dados, como vendas de novos e de reposição, demografia do país, epidemiologia de doenças e tarifas de importação e exportação, são alguns dos principais indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, são considerados a presença e disponibilidade de marcas do Médio Oriente e de África e os desafios enfrentados devido à elevada concorrência de marcas locais e nacionais, e o impacto dos canais de vendas, ao mesmo tempo que se fornece uma análise de previsão dos dados do país.

Cenário competitivo e análise da quota de mercado da citometria de fluxo no Médio Oriente e África

O panorama competitivo do mercado de citometria de fluxo no Médio Oriente e em África fornece detalhes sobre os concorrentes. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença no Médio Oriente e em África, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa, lançamento de produtos, largura do produto e amplitude e domínio de aplicação. Os dados acima fornecidos estão apenas relacionados com o foco da empresa no mercado de citometria de fluxo do Médio Oriente e África.

Alguns dos principais players que operam no mercado de citometria de fluxo do Médio Oriente e África são a Thermo Fisher Scientific Inc., BD, Bio-Rad Laboratories, Inc., Sysmex Corporation, Beckman Coulter, Inc., Merck KGaA, Enzo Biochem Inc ., Takara Bio Inc., Sartorius AG, Q2 Solutions (uma subsidiária da IQVIA), Elabscience Biotechnology Inc., ORFLO Technologies, entre outros.

SKU-28393